Russell Investments Group
PASG icon

Russell Investments Group’s Passage Bio PASG Stock Holding History

Russell Investments Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,034
Closed -$50K – 2945
2022
Q3 		$50K Sell
2,034
-2,292
-53% -$90.3K ﹤0.01% 2744
2022
Q2 		$204K Buy
4,326
+3,156
+270% +$147K ﹤0.01% 2537
2022
Q1 		$72K Buy
+1,170
New +$96.4K ﹤0.01% 2602

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Russell Investments Group's PASG Position: Q4 2022 in Review

Russell Investments Group sold out of Passage Bio (PASG) in Q4 2022, closing a stake of 2,034 shares — an estimated $50K sold.

Russell Investments Group first reported a position in PASG in Q1 2022 and held it in 3 quarters. The position peaked at $204K in Q2 2022. 67 funds tracked by Wall St. Rank hold PASG as of Q4 2022.

  • Russell Investments Group reported no remaining Passage Bio position as of Q4 2022 after selling out during the quarter.
  • Russell Investments Group sold 2,034 Passage Bio shares in Q4 2022, an estimated $50K.
  • Russell Investments Group first reported a position in Passage Bio in Q1 2022 and held it in 3 quarters.
  • Russell Investments Group's Passage Bio position peaked at $204K in Q2 2022.
  • 67 funds tracked by Wall St. Rank held Passage Bio as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.